Literature DB >> 26496229

Modulators of the human ABCC2: hope from natural sources?

Elisabeta Baiceanu1,2, Gianina Crisan2, Felicia Loghin3, Pierre Falson1.   

Abstract

Human ABCC2 is an ATP-binding cassette transporter involved in the export of endobiotics and xenobiotics. It is involved in cisplatin resistance in cancer cells, particularly in ovarian cancer. The few known ABCC2 modulators are poorly efficient, so it is necessary to explore new ways to select and optimize efficient compounds ABCC2. Natural products offer an original scaffold for such a strategy and brings hope for this aim. This review covers basic knowledge about ABCC2, from distribution and topology aspects to physiological and pathological functions. It summarizes the effect of natural products as ABCC2 modulators. Certain plant metabolites act on different ABCC2 regulation levels and therefore are promising candidates to block the multidrug resistance mediated by ABCC2 in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26496229     DOI: 10.4155/fmc.15.131

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  5 in total

1.  Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Authors:  Peng-Cheng Li; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek; Zhijian Duan; Qian-Yu Zhang; Ai-Xi Yu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2017-10-23       Impact factor: 3.922

2.  Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells.

Authors:  Margarita Melnikova; Ulrike Sophie Wauer; Diana Mendus; Ralf Axel Hilger; Trudy G Oliver; Kim Mercer; Björn Oliver Gohlke; Kati Erdmann; Dieter Niederacher; Hans Neubauer; Paul Buderath; Pauline Wimberger; Jan Dominik Kuhlmann; Jürgen Thomale
Journal:  Mol Oncol       Date:  2020-03-10       Impact factor: 6.603

Review 3.  A highly annotated database of genes associated with platinum resistance in cancer.

Authors:  Dongqing Huang; Sara R Savage; Anna P Calinawan; Chenwei Lin; Bing Zhang; Pei Wang; Timothy K Starr; Michael J Birrer; Amanda G Paulovich
Journal:  Oncogene       Date:  2021-10-13       Impact factor: 9.867

4.  The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients.

Authors:  Jia He; Zhan Wang; Ting Zou; Ying Wang; Xiang-Ping Li; Juan Chen
Journal:  Pharmgenomics Pers Med       Date:  2022-09-14

5.  Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.

Authors:  Yun Chen; Hongying Zhou; Sifu Yang; Dan Su
Journal:  Cell Biochem Funct       Date:  2020-08-20       Impact factor: 3.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.